Antenatal Receipt of Sulfadoxine-Pyrimethamine Does Not Exacerbate Pregnancy-Associated Malaria Despite the Expansion of Drug-Resistant Plasmodium falciparum: Clinical Outcomes From the QuEERPAM Study

Ítems similars

• Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study
  per: Taylor, Steve M, et al.
  Publicat: (2011)
• Mutations Associated with Sulfadoxine-Pyrimethamine and Chlorproguanil Resistance in Plasmodium falciparum Isolates from Blantyre, Malawi
  per: Alker, Alisa P., et al.
  Publicat: (2005)
• Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi
  per: Taylor, Steve M, et al.
  Publicat: (2020)
• In-vivo parasitological response to sulfadoxine-pyrimethamine in pregnant women in southern Malawi
  per: Msyamboza, K, et al.
  Publicat: (2007)
• The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women
  per: Gutman, Julie, et al.
  Publicat: (2015)